About
InvitroLinker is a proprietary protein-based additive developed by BioLinker to dramatically enhance the efficiency of swine artificial insemination (AI). Designed through synthetic biology and biomimetic engineering, this molecule improves sperm viability and motility—addressing a critical bottleneck in the reproductive success of Brazilian livestock systems.
In field and lab evaluations, InvitroLinker demonstrated up to 70% improvement in key sperm quality parameters, helping reduce the industry’s estimated US$ 600 million/year in losses due to dose degradation and failed fertilizations. Entirely developed and produced in Brazil, it offers a cost-effective, IP-protected alternative to high-cost, inconsistent imported products.
With a projected market share of US$ 45 million in Brazil and US$ 300 million globally in the swine cryopreservation segment, InvitroLinker is positioned to become a leading solution in reproductive biotechnology. The product is currently advancing through pilot production, tech transfer, and strategic partnerships with AI centers and manufacturers. Its roadmap includes expansion to bovine applications and a white-label model for global distribution.
Looking for
- Buyer
- Re-Seller/Wholesaler
- Commercial agent
Applies to
- Biotech, Pharma and Cosmetics
Attached files
Organisation
Similar opportunities
Investment
- Seed and Development
- Biotech, Pharma and Cosmetics
Oliveira Mona
CEO at BioLinker
Cotia, Brazil
Service
Support of the chemical products export (SDS, standartization, consulting)
- Consulting
- Certification
- Education, Training & Qualifying
Tuyana Norboeva
specialist at Coordinating Informational Center of CIS Member States on approximation of regulatory practices (CIS Center)
Moscow, Russia